खोज परिणाम - M. Yu. Fedyanin

  • प्रदर्शित 1 - 10 परिणाम 10
परिणाम को परिष्कृत करें
  1. 1

    Heterogeneity and clonal evolution of colorectal cancer द्वारा M. Yu. Fedyanin, H. H.-M. Elsnukaeva, S. A. Tjulandin

    प्रकाशित 2017-04-01

    There are a lot of studies that dedicated to genetic differences between the primary tumor and metastases. This becomes relevant not only for molecular biologists for understanding carcinogenesis, but also becoming increasingly important for medical oncologists, due to the possible impact on the cho...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  2. 2

    Prospects of therapeutic action on FGFR signaling pathway द्वारा M. Yu. Fedyanin, D. N. Khmelkova, T. S. Serebriyskaya, T. A. Nikolskaya, S. A. Tyulyandin

    प्रकाशित 2015-06-01

    Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in key cellular functions and cancerogenesis. Nowadays FGFR and their ligands are one of the most investigated markers in oncology and targets for specific therapy. There are a lot of clinical trials in on- cology include drug...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  3. 3

    Effcacy and toxicity of regorafenib compared to reintrodaction of chemotherapy in metastatic colon cancer: retrospective multicenter study द्वारा E. S. Kuzmina, M. Yu. Fedyanin, I. V. Reshetov, I. A. Pokataev, V. N. Galkin

    प्रकाशित 2023-09-01

    The objective of the study is to compare the effectiveness of various systemic therapies in the 3rd and subsequent lines of therapy of metastatic colon cancer. Material and Methods. Retrospective multicenter study collected data from 2 clinics of the Russian Federation. We considered overall surviva...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  4. 4

    Nivolumab in real-life clinical practice द्वारा M. A. Lyadova, O. A. Pardabekova, R. R. Shakirov, V. K. Lyadov, M. Yu. Fedyanin

    प्रकाशित 2019-12-01

    Purpose of the study. To evaluate the efficacy and tolerability of nivolumab in oncologic patients in real-life clinical seffings.Patients and methods. Analysis included 114 patients aged 26-96 years with melanoma (n = 64), non-small cell lung carcinoma (NSCLC) (n = 37) and metastatic colorectal can...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  5. 5

    PROGNOSTIC FACTORS IN THE TREATMENT OF LUNG METASTASES FROM COLORECTAL CANCER द्वारा B. B. Akhmedov, M. M. Davydov, M. Yu. Fedyanin, V. A. Aliev, S. S. Gordeev, I. A. Dadyev

    प्रकाशित 2018-05-01

    Based on the results of worldwide clinical studies, survival of colorectal cancer patients with lung metastases is significantly influenced by curative resection, number of metastases and disease free interval. Intrathoracic lymph node metastases in combination with pulmonary metastases as well as t...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  6. 6

    OVARIAN DYSGERMINOMAS: TREATMENT EXPERIENCE OF THE N.N.BLOKHIN CRC RAMS द्वारा O. N. Streltzova, M. Yu. Fedyanin, A. A. Tryakin, A. A. Bulanov, V. V. Zhordania, S. A. Tyulandin

    प्रकाशित 2014-09-01

    This is a retrospective review of treatment results of 35 patients with dysgerminomas in the Departments of Clinical Pharmacology and Gynecology, N.N.Blokhin Russian Cancer Research Center (NNBRCRC) between 1990 and 2006.Primary surgery was carried out in all patients. Twenty patients (57%) underwen...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  7. 7

    Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria) द्वारा M. Yu. Fedyanin, A. V. Snegovoy, V. V. Breder, Yu. N. Linkova, A. V. Zinkina-Orikhan, S. B. Setkina, S. N. Fogt, V. S. Chistiakov, N. A. Kravtsova

    प्रकाशित 2023-06-01

    In recent years, there has been a significant increase in the number of patients with malignancies treated with immune checkpoint inhibitors (ICIs), including the anti-programmed cell death protein 1 (anti–PD-1) agent pembrolizumab. One of the important aspects of conducting clinical trials with ICI...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  8. 8

    Molecular portrait of stomach cancer associated with the Epstein–Barr virus द्वारा E. O. Ignatova, D. A. Seryak, M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. F. Menshikova, Yu. V. Vakhabova, M. S. Karbyshev, K. V. Smirnova, S. A. Tulyandin

    प्रकाशित 2020-11-01

    Epstein–Barr virus (EBV) associated gastric carcinoma is a special form of gastric adenocarcinoma that arises against the background of clonal growth of EBV-infected epithelial cells of the gastric mucosa. This subtype of tumors has unique genetic and epigenetic features that determine its character...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  9. 9

    The prognostic value of circulating in blood tumor DNA as a marker of minimal residual disease in stage I–III colorectal cancer द्वारा E. M. Polyanskaya, M. Yu. Fedyanin, U. A. Boyarskikh, A. A. Kechin, E. A. Moroz, E. A. Khrapov, I. P. Oskorobin, D. V. Shamovskaya, V. A. Aliev, Z. Z. Mammadli, A. A. Tryakin, M. L. Filipenko, S. A. Tyulendin

    प्रकाशित 2022-06-01

    Introduction. Studies on non-metastatic colorectal cancer have demonstrated the prognostic role of circulating tumor (ctDNA) after surgery, and the ability to identify patients with the greatest risk of progression. This makes it possible in the future to personalize neoadjuvant and adjuvant treatme...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख
  10. 10

    Validation of high-throughput sequencing-based test system for detection of microsatellite instability in colorectal cancer samples द्वारा A. A. Lebedeva, A. N. Taraskina, A. I. Kavun, E. V. Belova, T. V. Grigor'eva, O. A. Kuznetsova, D. A. Kravchuk, L. D. Belyaeva, V. E. Nikulin, E. D. Khomenko, V. A. Mileyko, A. A. Tryakin, M. Yu. Fedyanin, M. V. Ivanov

    प्रकाशित 2025-04-01

    Introduction. Currently in routine clinical practice, standard methods based on polymerase chain reaction (PCR) and immunohistochemical examination are used to determine microsatellite instability (MSI) and deficient mismatch repair system (dMMR). MSI identification using high-throughput sequencing...

    पूर्ण विवरण

    पूर्ण पाठ प्राप्त करें
    लेख